The provision for the inclusion of socio-economic considerations in domestic regulatory frameworks pertaining to living modified organisms has been established by Article 26 of the Cartagena Protocol on Biosafety to the Convention on Biological Diversity. Many countries are considering, or have...

This article examines three developing countries to identify capacities for innovative science policy: Brazil, South Africa and the Philippines. Using membership in regional trading agreements, we assess whether these three nations have aligned their science/innovation policy with the partners...